INTERVIEW: Get your EU clinical evaluation report shipshape or get your products pulled
This article was originally published in Clinica
Executive Summary
It may still be several years before the new EU regulation for medical devices come into full force, but if the medtech industry does not keep up to date with current changes to clinical evaluation requirements, it could well find its products pulled from the market. Amanda Maxwell spoke with Sarah Sorrel, founder and president of MedPass International, to find out what manufacturers need to know to ensure they do not fall on the wrong side of the regulators
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.